Isolation and retrieval of circulating tumor cells using centrifugal forces

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Hou, Han Wei ^a,b   Warkiani, Majid Ebrahimi ^b   Khoo, Bee Luan ^c   Li, Zi Rui ^b   Soo, Ross A ^d,e,f   Tan, Daniel Shao Weng ^g   Lim, Wan Teck ^g   Han, Jongyoon ^a,b,h   Bhagat, Ali Asgar S ^b,j   Lim, Chwee Teck ^b,c,i  

^a USA   (United States)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^h Massachusetts Institute of Technology Cambridge   (United States)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j S BIO Pte Ltd   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN; KERATIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ARTICLE; BLOOD CELL; CELL SEPARATION; CELL STRAIN MCF 7; CENTRIFUGATION; CYTOLOGY; EQUIPMENT; HUMAN; LUNG TUMOR; METABOLISM; METHODOLOGY; MICROFLUIDIC ANALYSIS; PATHOLOGY; TUMOR CELL LINE; TUMOR EMBOLISM;

ANTIGENS, CD; ANTIGENS, CD45; BLOOD CELLS; CELL LINE, TUMOR; CELL SEPARATION; CENTRIFUGATION; GLYCOPROTEINS; HUMANS; KERATINS; LUNG NEOPLASMS; MCF-7 CELLS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASTIC CELLS, CIRCULATING; PEPTIDES;

EID: 84874309411     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01259     Document Type: Article

References (49)

1. Budd, G. T. et al. Circulating tumor cells versus imaging-Predicting overall survival in metastatic breast cancer. Clin. Cancer Res. 12, 6403-6409 (2006).
2. Cristofanilli, M. et al. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. N Engl J Med 351, 781-791 (2004).
3. Hayes, D. F. et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 12, 4218-4224 (2006).
4. Punnoose, E. A. et al. Molecular Biomarker Analyses Using Circulating Tumor Cells. PLoS ONE 5, e12517 (2010).
5. Maheswaran, S. et al. DetectionofMutationsinEGFRinCirculating Lung-Cancer Cells. New England Journal of Medicine 359, 366-377 (2008).
6. Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329-340 (2008).
7. Vona, G. et al. Isolation by size of epithelial tumor cells-A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156, 57-63 (2000).
8. Riethdorf, S. et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System. Clin. Cancer Res. 13, 920-928 (2007).
9. Mohamed, H., Murray, M., Turner, J. N. & Caggana, M. Isolation of tumor cells using size and deformation. J. Chromatogr. A 1216, 8289-8295 (2009).
10. Zheng, S. et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 1162, 154-161 (2007).
11. Tan, S., Yobas, L., Lee, G., Ong, C. & Lim, C. Microdevice for the isolation and enumeration of cancer cells from blood. Biomedical Microdevices 11, 883-892 (2009).
12. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
13. Adams, A. A. et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J. Am. Chem. Soc. 130, 8633-8641 (2008).
14. Gleghorn, J. P. et al. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip 10, 27-29 (2010).
15. Xu, Y. et al. Aptamer-Based Microfluidic Device for Enrichment, Sorting, and Detection of Multiple Cancer Cells. Anal. Chem. 81, 7436-7442 (2009).
16. Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proceedings of the National Academy of Sciences 107, 18392-18397 (2010).
17. Saliba, A.-E. et al. Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proceedings of the National Academy of Sciences 107, 14524-14529 (2010).
18. Spizzo, G. et al. High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer. Breast Cancer Research and Treatment 86, 207-213 (2004).
19. 2 CTCs. Cancer Discovery 1, 580-586 (2011).
20. Squires, T. M. & Quake, S. R. Microfluidics: Fluid physics at the nanoliter scale. Rev. Mod. Phys. 77, 977-1026 (2005).
21. Seo, J., Lean, M. H. & Kole, A. Membrane-free microfiltration by asymmetric inertial migration. Appl. Phys. Lett. 91, 3 (2007).
22. Di Carlo, D., Irimia, D., Tompkins, R. G. & Toner, M. Continuous inertial focusing, ordering, and separation of particles in microchannels. Proc. Natl. Acad. Sci. U. S. A. 104, 18892-18897 (2007).
23. Di Carlo, D. Inertial microfluidics. Lab Chip 9, 3038-3046 (2009).
24. Bhagat, A. A. S., Hou, H. W., Li, L. D., Han, J. Y. & Lim, C. T. Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation. Lab Chip 11, 1870-1878 (2011).
25. Kuntaegowdanahalli, S. S., Bhagat, A. A. S., Kumar, G. & Papautsky, I. Inertial microfluidics for continuous particle separation in spiral microchannels. Lab Chip 9, 2973-2980 (2009).
26. Russom, A. et al. Differential inertial focusing of particles in curved low-aspect-ratio microchannels. New J. Phys. 11, 9 (2009).
27. Lee, W. C. et al. High-throughput cell cycle synchronization using inertial forces in spiral microchannels. Lab Chip 11, 1359-1367 (2011).
28. Hou, H. W. et al. Microfluidic Devices for Blood Fractionation. Micromachines 2, 319-343 (2011).
29. Hur, S. C., Mach, A. J. & Carlo, D. D. High-throughput size-based rare cell enrichment using microscale vortices. Biomicrofluidics 5, 022206 (2011).
30. Bhagat, A. A. S., Kuntaegowdanahalli, S. S. & Papautsky, I. Continuous particle separation in spiral microchannels using dean flows and differential migration. Lab Chip 8, 1906-1914 (2008).
31. Dean, W. The stream-line motion of fluid in a curved pipe. Philosophical Magazine Series 7 5, 673-695 (1928).
32. Ookawara, S., Street, D. & Ogawa, K. Numerical study on development of particle concentration profiles in a curved microchannel. Chemical Engineering Science 61, 3714-3724 (2006).
33. Zabaglo, L. et al. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry Part A 55, 102-108 (2003).
34. Bhagat, A. A. S., Kuntaegowdanahalli, S. S. & Papautsky, I. Enhanced particle filtration in straight microchannels using shear-modulated inertial migration. Physics of Fluids 20, 101702 (2008).
35. Cho, E. H. et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Physical Biology 9, 016001 (2012).
36. Hou, J.-M. et al. Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology 30, 525-532 (2012).
37. Edward, H. C. et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Physical Biology 9, 016001 (2012).
38. Bertolini, G. et al. Highly tumorigenic lung cancer CD1331 cells display stem-like features and are spared by cisplatin treatment. Proceedings of the National Academy of Sciences 106, 16281-16286 (2009).
39. Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15, 504-514 (2007).
40. den Toonder, J. Circulating tumor cells: the Grand Challenge. Lab Chip 11, 375-377 (2011).
41. Lee, J. M., Dedhar, S., Kalluri, R. & Thompson, E. W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981 (2006).
42. Mani, S. A. et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell 133, 704-715 (2008).
43. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 100, 3983-3988 (2003).
44. Li, X. et al. Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy. Journal of the National Cancer Institute 100, 672-679 (2008).
45. Lin, H. K. et al. Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells. Clin. Cancer Res. 16, 5011-5018 (2010).
46. Marrinucci, D. et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Physical Biology 9, 016003 (2012).
47. Theodoropoulos, P. A. et al. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Letters 288, 99-106 (2010).
48. Aktas, B. et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research 11, R46 (2009).
49. Hou, H. W. et al. Deformability based cell margination-A simple microfluidic design for malaria-infected erythrocyte separation. Lab on a Chip 10, 2605-2613 (2010).